abstract |
The present invention regards a mixture in solid form comprising or, alternatively, consisting of (a) alginic acid, or a salt thereof, (b) a bicarbonate and/or carbonate salt and (c) a simethicone and/or dimethicone, for use in a treatment, in particular in a curative and/or preventive treatment, of extraoesophageal disorders or symptoms caused or triggered by gastroesophageal reflux disease (GERD) or by a partial backflow of the gastric content, such as for example by the partial backflow of pepsin, hydrochloric acid, gastric juices or acid gastric vapours, from the stomach and which occur, said disorders or symptoms, in an extraoesophageal area. |